SAA2 and obesity disorder: Emerging evidence has implicated chronically elevated SAA in the pathogenesis of several cardiometabolic diseases, including obesity, type 2 diabetes mellitus (T2DM), MASLD and hypertension [18, 69, 105, 125, 168].